Reply to Eljaaly et al

TO THE EDITOR—This response is written on behalf of the members of the Infectious Diseases Society of America (IDSA) Skin and Soft Tissue Guidelines Committee. Thank you for your thoughtful response [1] to the IDSA Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections 2014 [2]. We agree that in Table 3 the dose of ciprofloxacin could be either 500 mg PO every 12 hours or a range of 500 to 750 mg PO every 12 hours. We also agree that from Table 4 the recommended dose for treatment of Aeromonas hydrophila necrotizing infection should be 400 mg IV every 12 hours and that the dose of ceftriaxone for treatment of Vibrio vulnificus should be 1 gram IV every day (qd) and not qid. An erratum has been issued correcting Table 4 in Clinical Infectious Diseases.